The Rgr oncogene (homologous to RalGDS) induces transformation and gene expression by activating Ras, Ral and Rho...

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• The Rgr oncogene, a guanine exchange factor for Ral, has demonstrated in vitro activity.
• Investigating the in vivo effects of Rgr on cellular processes is crucial for understanding its oncogenic potential.

Purpose of the Study:

• To investigate the effects of the 5'-truncated Rgr oncogene on cell proliferation, transformation, and gene expression.
• To elucidate the specific signaling pathways activated by Rgr, particularly its role in Ras and Ral activation.

Main Methods:

• Establishment of TetRgr cell lines for tetracycline-inducible Rgr expression.
• Analysis of cell morphology, growth patterns, and transcriptional activity (serum response element, c-Jun).
• Assessment of kinase phosphorylation (ERKs, p38, JNK) and GTP-bound Ras/Ral levels; use of dominant-negative mutants.

Main Results:

• Rgr overexpression leads to morphological transformation and disorganized cell growth.
• Rgr enhances serum response element and c-Jun activity, phosphorylates ERKs, p38, and JNK kinases.
• Rgr increases GTP-bound Ral and Ras, with Ras activation being key to its broad effects; the Ras-Raf-MEK-ERK cascade is essential for transformation.

Conclusions:

• The Rgr oncogene drives cell transformation and proliferation through the Ras-Raf-MEK-ERK signaling cascade.
• Rgr's effects are mediated by Ras activation, independent of Grb2-dependent feedback mechanisms.
• Targeting Rgr-induced pathways presents a potential strategy for cancer therapy.